Karen S. Wilcox

University of Utah, Salt Lake City, UT 
basic mechanisms of epilepsy, anticonvulsant drug development
"Karen Wilcox"
Mean distance: 14.41 (cluster 11)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Wallis GJ, Bell LA, Wagner JN, et al. (2024) Reactive microglia fail to respond to environmental damage signals in a viral-induced mouse model of temporal lobe epilepsy. Biorxiv : the Preprint Server For Biology
Lee JE, Wilcox K, Jacobson KA, et al. (2024) Adenosine Receptor Subtypes and Cardioprotection. Drug Development Research. 45: 394-401
Cornelssen C, Finlinson E, Rolston JD, et al. (2023) Ultrasonic therapies for seizures and drug-resistant epilepsy. Frontiers in Neurology. 14: 1301956
Cornelssen C, Payne A, Parker D, et al. (2023) Development of an MR-guided focused ultrasound (MRgFUS) lesioning approach for small and deep structures in the rat brain. Biorxiv : the Preprint Server For Biology
Anderson DN, Charlebois CM, Smith EH, et al. (2023) Closed-loop stimulation in periods with less epileptiform activity drives improved epilepsy outcomes. Brain : a Journal of Neurology
Batot G, Metcalf CS, Bell LA, et al. (2022) A Model for Epilepsy of Infectious Etiology using Theiler's Murine Encephalomyelitis Virus. Journal of Visualized Experiments : Jove
DePaula-Silva AB, Bell LA, Wallis GJ, et al. (2021) Inflammation Unleashed in Viral-Induced Epileptogenesis. Epilepsy Currents. 21: 433-440
West PJ, Thomson K, Billingsley P, et al. (2021) Spontaneous recurrent seizures in an intra-amygdala kainate microinjection model of temporal lobe epilepsy are differentially sensitive to antiseizure drugs. Experimental Neurology. 349: 113954
Barker-Haliski M, Knox K, Zierath D, et al. (2021) Development of an antiepileptogenesis drug screening platform: Effects of everolimus and phenobarbital. Epilepsia
Galanopoulou AS, Löscher W, Lubbers L, et al. (2021) Antiepileptogenesis and disease modification: Progress, challenges, and the path forward-Report of the Preclinical Working Group of the 2018 NINDS-sponsored antiepileptogenesis and disease modification workshop. Epilepsia Open
See more...